These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types. Farrell DJ, Flamm RK, Sader HS, Jones RN. Int J Antimicrob Agents; 2014 Apr; 43(4):323-7. PubMed ID: 24411474 [Abstract] [Full Text] [Related]
18. Evaluating the antibacterial activity of ceftaroline against clinical isolates of methicillin-susceptible and- resistant Staphylococcus aureus in Kuwait hospitals. Alfouzan W, Boswihi SS, Dhar R, Udo E. J Infect Public Health; 2020 Oct; 13(10):1589-1591. PubMed ID: 32859552 [Abstract] [Full Text] [Related]
19. Detection of staphylococcal cassette chromosome mec-associated DNA segments in multiresistant methicillin-susceptible Staphylococcus aureus (MSSA) and identification of Staphylococcus epidermidis ccrAB4 in both methicillin-resistant S. aureus and MSSA. Shore AC, Rossney AS, O'Connell B, Herra CM, Sullivan DJ, Humphreys H, Coleman DC. Antimicrob Agents Chemother; 2008 Dec; 52(12):4407-19. PubMed ID: 18852274 [Abstract] [Full Text] [Related]